Winning Best of Show Again: A Reflection on MLADU, Research Data, and the Bio-IT World Community
Award Commentary by Dana Cottrell, President Dantech Corp.
July 21, 2026 | When Dantech Corporation created MLADU, we were not trying to build a product that would win awards. We were trying to solve a problem that we kept seeing in the real world: research organizations, consortia, biopharma teams, clinical partners, and technology teams needed to move important data securely, reliably, and with accountability, but the process was often far more slow and difficult than it should be.
Winning Bio-IT World Best of Show for the second year in a row is therefore both deeply meaningful and humbling. It is meaningful because the Bio-IT World community understands the problem MLADU was built to address. It is humbling because this recognition came from people who work every day at the intersection of science, technology, operations, compliance, and collaboration. These are people who do not need a theoretical explanation of why data movement matters. They live it.
To everyone who visited our booth, spent time with us, asked thoughtful questions, challenged assumptions, shared your own transfer challenges, and voted for MLADU, thank you. We are grateful for your time, your feedback, and your confidence. Booth conversations at Bio-IT World are rarely superficial. They often begin with a polite introduction and quickly become very specific. Someone mentions a multi-terabyte transfer that stalled. Someone else describes a project involving millions of files, multiple institutions, and an urgent deadline. A third person quietly asks, “Can this also give me an audit trail?”
The reason MLADU resonates is simple: research data has become too valuable, too distributed, too large, and too governed to be moved casually.
Across the Bio-IT World community, data is not merely a technical asset. It represents patient participation, research investment, institutional trust, scientific possibility, and often years of work. Genomic data, imaging data, clinical research data, omics data, operational data, and partner data all have one thing in common: they need to move. They need to move between organizations, cloud environments, research platforms, collaborators, and downstream teams. They need to move securely. They need to move with visibility. They need to move without turning every transfer into a special project that consumes scarce technical resources.
In theory, moving data should be straightforward. In practice, anyone who has ever dealt with large research data transfers knows that “just send the files” is one of the most optimistic phrases in technology. It sounds simple until the data is measured in terabytes, the file count is measured well above hundreds of thousands, the source system has constraints, the destination system has different constraints, the approving stakeholder is traveling, the compliance team wants evidence, and the deadline was last Thursday.
This is the need that MLADU addresses.
MLADU was designed to help organizations move large and complex data sets across cloud, consortium, partner, and research environments with greater speed, security, visibility, and control. It supports the reality that data transfer is not only about bandwidth. It is about coordination. It is about governance. It is about knowing who sent what, who approved it, when it moved, where it went, and whether it arrived as expected. It is about making the operational side of research collaboration less painful.
That last phrase matters. Less painful.
Technology does not always need to be dramatic to be valuable. Sometimes the most important products are the ones that reduce friction in the background so important work can continue in the foreground. If MLADU helps a research team avoid months of delay, gives a consortium clearer transfer accountability, helps a technical team support a partner without building and babysitting a one-off workflow, or provides an audit trail when someone inevitably asks for one, then MLADU is doing what it was built to do.
As founder and president of Dantech Corporation, I also see MLADU as part of a larger leadership responsibility. We serve organizations that are doing serious work. Many of them are advancing biomedical research, supporting rare disease communities, enabling clinical discovery, and building shared data ecosystems. They need partners who listen carefully, understand operational constraints, and build practical solutions that respect the environments in which research actually happens.
That has shaped how we think about MLADU. We believe secure data transfer should not require every organization to become a transfer engineering shop. We believe research collaboration should not be slowed down because the data is too large, too complex, or too difficult to govern. We believe visibility and auditability should be built into the process, not reconstructed later through inbox archaeology.
The Bio-IT World community is especially important because it brings together the people who understand both the promise and the burden of modern research data. The promise is enormous. Data sharing can accelerate discovery, improve collaboration, support reproducibility, enable new analytics, and help research investments reach further. The burden is also real. The larger and more distributed the data becomes, the harder it is to manage responsibly. Every organization wants innovation. No organization wants uncontrolled movement of sensitive or regulated data.
That is the balance MLADU is intended to support. Move the data, but do it responsibly. Make transfers faster, but not reckless. Improve collaboration, but preserve governance. Reduce complexity, but not visibility. Support scale, but do not treat security as an afterthought.
Winning Best of Show for a second consecutive year tells us that this balance matters to the community. It tells us that the problem is not isolated. It tells us that many organizations are searching for better ways to move research data without adding unnecessary operational drag. It also reminds us that the best product feedback often comes from the people closest to the work. Many of the most valuable insights we receive come from conversations with researchers, data managers, IT leaders, compliance professionals, and operations teams who are trying to make collaboration happen under real-world constraints.
We do not take this recognition lightly. Awards are encouraging, but they are also clarifying. They raise the standard. They remind us that MLADU must continue to improve, continue to listen, and continue to solve practical problems for the people and organizations that trusted us with their attention and their vote.
To the Bio-IT World community, thank you for recognizing MLADU again. Thank you for seeing the need behind the product. Thank you for the conversations, the questions, the encouragement, and the constructive skepticism. The skepticism is especially welcome. In technology, unchecked enthusiasm has caused more than one dashboard to be created that no one asked for.
At Dantech, we are proud of what MLADU has achieved, but we are even more focused on what it can help others achieve. If secure, visible, governed data transfer becomes a little easier for research organizations, then collaboration becomes a little easier. If collaboration becomes easier, discovery can move faster. And if discovery moves faster, then the value extends far beyond the software itself.
That is why MLADU exists. That is why this award matters. And that is why we are grateful to the Bio-IT World community for helping us continue the work.


